Loading…

miR-200b downregulates Kruppel Like Factor 2 (KLF2) during acute hypoxia in human endothelial cells

The role of microRNAs in controlling angiogenesis is recognized as a promising therapeutic target in both cancer and cardiovascular disorders. However, understanding a miRNA’s pleiotropic effects on angiogenesis is a limiting factor for these types of therapeutic approaches. Using genome-wide next-g...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cell biology 2017-12, Vol.96 (8), p.758-766
Main Authors: Bartoszewski, Rafal, Serocki, Marcin, Janaszak-Jasiecka, Anna, Bartoszewska, Sylwia, Kochan-Jamrozy, Kinga, Piotrowski, Arkadiusz, Króliczewski, Jarosław, Collawn, James F.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c455t-32ff75fb3eb0c45433285090230a18434b8532d9c18be045fe1229d12eb58d3b3
cites cdi_FETCH-LOGICAL-c455t-32ff75fb3eb0c45433285090230a18434b8532d9c18be045fe1229d12eb58d3b3
container_end_page 766
container_issue 8
container_start_page 758
container_title European journal of cell biology
container_volume 96
creator Bartoszewski, Rafal
Serocki, Marcin
Janaszak-Jasiecka, Anna
Bartoszewska, Sylwia
Kochan-Jamrozy, Kinga
Piotrowski, Arkadiusz
Króliczewski, Jarosław
Collawn, James F.
description The role of microRNAs in controlling angiogenesis is recognized as a promising therapeutic target in both cancer and cardiovascular disorders. However, understanding a miRNA’s pleiotropic effects on angiogenesis is a limiting factor for these types of therapeutic approaches. Using genome-wide next-generation sequencing, we examined the role of an antiangiogenic miRNA, miR-200b, in primary human endothelial cells. The results indicate that miR-200b has complex effects on hypoxia-induced angiogenesis in human endothelia and importantly, that many of the reported miR-200b effects using miRNA overexpression may not be representative of the physiological role of this miRNA. We also identified the antiangiogenic KLF2 gene as a novel target of miR-200b. Our studies indicate that the physiological changes in miR-200b levels during acute hypoxia may actually have a proangiogenic effect through Klf2 downregulation and subsequent stabilization of HIF-1 signaling. Moreover, we provide a viable approach for differentiating direct from indirect miRNA effects in order to untangle the complexity of individual miRNA networks.
doi_str_mv 10.1016/j.ejcb.2017.10.001
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5677561</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0171933517301954</els_id><sourcerecordid>1952525383</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-32ff75fb3eb0c45433285090230a18434b8532d9c18be045fe1229d12eb58d3b3</originalsourceid><addsrcrecordid>eNp9kV9rFDEUxYModlv9Aj5IHuvDrPkz2UlAhFJclS4Ios8hydzZzTqTjMlMtd--GbYWfZE8BM793XOTexB6RcmaErp5e1zD0dk1I7QpwpoQ-gSt6IbKijIln6JVKdBKcS7O0HnOxwIIqdRzdMYUqRlp2Aq5wX-tGCEWt_FXSLCfezNBxjdpHkfo8c7_ALw1booJM3x5s9uyN7idkw97bNw8AT7cjfG3N9gHfJgHEzCENk4H6L3psYO-zy_Qs870GV4-3Bfo-_bDt-tP1e7Lx8_XV7vK1UJMFWdd14jOcrCkKDXnTAqiCOPEUFnz2krBWasclRZILTqgjKmWMrBCttzyC_T-5DvOdoDWQZiS6fWY_GDSnY7G638rwR_0Pt5qsWkasaHF4PLBIMWfM-RJDz4vXzAB4pw1VYKVwyUvKDuhLsWcE3SPYyjRSzr6qJd09JLOopXll6bXfz_wseVPHAV4dwKgrOnWQ9LZeQgOWp_ATbqN_n_-91j-n-E</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1952525383</pqid></control><display><type>article</type><title>miR-200b downregulates Kruppel Like Factor 2 (KLF2) during acute hypoxia in human endothelial cells</title><source>ScienceDirect Journals</source><creator>Bartoszewski, Rafal ; Serocki, Marcin ; Janaszak-Jasiecka, Anna ; Bartoszewska, Sylwia ; Kochan-Jamrozy, Kinga ; Piotrowski, Arkadiusz ; Króliczewski, Jarosław ; Collawn, James F.</creator><creatorcontrib>Bartoszewski, Rafal ; Serocki, Marcin ; Janaszak-Jasiecka, Anna ; Bartoszewska, Sylwia ; Kochan-Jamrozy, Kinga ; Piotrowski, Arkadiusz ; Króliczewski, Jarosław ; Collawn, James F.</creatorcontrib><description>The role of microRNAs in controlling angiogenesis is recognized as a promising therapeutic target in both cancer and cardiovascular disorders. However, understanding a miRNA’s pleiotropic effects on angiogenesis is a limiting factor for these types of therapeutic approaches. Using genome-wide next-generation sequencing, we examined the role of an antiangiogenic miRNA, miR-200b, in primary human endothelial cells. The results indicate that miR-200b has complex effects on hypoxia-induced angiogenesis in human endothelia and importantly, that many of the reported miR-200b effects using miRNA overexpression may not be representative of the physiological role of this miRNA. We also identified the antiangiogenic KLF2 gene as a novel target of miR-200b. Our studies indicate that the physiological changes in miR-200b levels during acute hypoxia may actually have a proangiogenic effect through Klf2 downregulation and subsequent stabilization of HIF-1 signaling. Moreover, we provide a viable approach for differentiating direct from indirect miRNA effects in order to untangle the complexity of individual miRNA networks.</description><identifier>ISSN: 0171-9335</identifier><identifier>EISSN: 1618-1298</identifier><identifier>DOI: 10.1016/j.ejcb.2017.10.001</identifier><identifier>PMID: 29042072</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Cell Hypoxia - genetics ; Down-Regulation ; HIF-1 ; HIF-2 ; hsa-miR-200b-3p ; Human Umbilical Vein Endothelial Cells ; Humans ; HUVEC ; KLF2 ; Kruppel-Like Transcription Factors - genetics ; Kruppel-Like Transcription Factors - metabolism ; Micro-RNA 200b ; MicroRNAs - genetics ; MicroRNAs - metabolism ; Neovascularization, Physiologic - genetics ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; Transfection</subject><ispartof>European journal of cell biology, 2017-12, Vol.96 (8), p.758-766</ispartof><rights>2017 Elsevier GmbH</rights><rights>Copyright © 2017 Elsevier GmbH. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-32ff75fb3eb0c45433285090230a18434b8532d9c18be045fe1229d12eb58d3b3</citedby><cites>FETCH-LOGICAL-c455t-32ff75fb3eb0c45433285090230a18434b8532d9c18be045fe1229d12eb58d3b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29042072$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bartoszewski, Rafal</creatorcontrib><creatorcontrib>Serocki, Marcin</creatorcontrib><creatorcontrib>Janaszak-Jasiecka, Anna</creatorcontrib><creatorcontrib>Bartoszewska, Sylwia</creatorcontrib><creatorcontrib>Kochan-Jamrozy, Kinga</creatorcontrib><creatorcontrib>Piotrowski, Arkadiusz</creatorcontrib><creatorcontrib>Króliczewski, Jarosław</creatorcontrib><creatorcontrib>Collawn, James F.</creatorcontrib><title>miR-200b downregulates Kruppel Like Factor 2 (KLF2) during acute hypoxia in human endothelial cells</title><title>European journal of cell biology</title><addtitle>Eur J Cell Biol</addtitle><description>The role of microRNAs in controlling angiogenesis is recognized as a promising therapeutic target in both cancer and cardiovascular disorders. However, understanding a miRNA’s pleiotropic effects on angiogenesis is a limiting factor for these types of therapeutic approaches. Using genome-wide next-generation sequencing, we examined the role of an antiangiogenic miRNA, miR-200b, in primary human endothelial cells. The results indicate that miR-200b has complex effects on hypoxia-induced angiogenesis in human endothelia and importantly, that many of the reported miR-200b effects using miRNA overexpression may not be representative of the physiological role of this miRNA. We also identified the antiangiogenic KLF2 gene as a novel target of miR-200b. Our studies indicate that the physiological changes in miR-200b levels during acute hypoxia may actually have a proangiogenic effect through Klf2 downregulation and subsequent stabilization of HIF-1 signaling. Moreover, we provide a viable approach for differentiating direct from indirect miRNA effects in order to untangle the complexity of individual miRNA networks.</description><subject>Cell Hypoxia - genetics</subject><subject>Down-Regulation</subject><subject>HIF-1</subject><subject>HIF-2</subject><subject>hsa-miR-200b-3p</subject><subject>Human Umbilical Vein Endothelial Cells</subject><subject>Humans</subject><subject>HUVEC</subject><subject>KLF2</subject><subject>Kruppel-Like Transcription Factors - genetics</subject><subject>Kruppel-Like Transcription Factors - metabolism</subject><subject>Micro-RNA 200b</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>Neovascularization, Physiologic - genetics</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>Transfection</subject><issn>0171-9335</issn><issn>1618-1298</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kV9rFDEUxYModlv9Aj5IHuvDrPkz2UlAhFJclS4Ios8hydzZzTqTjMlMtd--GbYWfZE8BM793XOTexB6RcmaErp5e1zD0dk1I7QpwpoQ-gSt6IbKijIln6JVKdBKcS7O0HnOxwIIqdRzdMYUqRlp2Aq5wX-tGCEWt_FXSLCfezNBxjdpHkfo8c7_ALw1booJM3x5s9uyN7idkw97bNw8AT7cjfG3N9gHfJgHEzCENk4H6L3psYO-zy_Qs870GV4-3Bfo-_bDt-tP1e7Lx8_XV7vK1UJMFWdd14jOcrCkKDXnTAqiCOPEUFnz2krBWasclRZILTqgjKmWMrBCttzyC_T-5DvOdoDWQZiS6fWY_GDSnY7G638rwR_0Pt5qsWkasaHF4PLBIMWfM-RJDz4vXzAB4pw1VYKVwyUvKDuhLsWcE3SPYyjRSzr6qJd09JLOopXll6bXfz_wseVPHAV4dwKgrOnWQ9LZeQgOWp_ATbqN_n_-91j-n-E</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>Bartoszewski, Rafal</creator><creator>Serocki, Marcin</creator><creator>Janaszak-Jasiecka, Anna</creator><creator>Bartoszewska, Sylwia</creator><creator>Kochan-Jamrozy, Kinga</creator><creator>Piotrowski, Arkadiusz</creator><creator>Króliczewski, Jarosław</creator><creator>Collawn, James F.</creator><general>Elsevier GmbH</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20171201</creationdate><title>miR-200b downregulates Kruppel Like Factor 2 (KLF2) during acute hypoxia in human endothelial cells</title><author>Bartoszewski, Rafal ; Serocki, Marcin ; Janaszak-Jasiecka, Anna ; Bartoszewska, Sylwia ; Kochan-Jamrozy, Kinga ; Piotrowski, Arkadiusz ; Króliczewski, Jarosław ; Collawn, James F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-32ff75fb3eb0c45433285090230a18434b8532d9c18be045fe1229d12eb58d3b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Cell Hypoxia - genetics</topic><topic>Down-Regulation</topic><topic>HIF-1</topic><topic>HIF-2</topic><topic>hsa-miR-200b-3p</topic><topic>Human Umbilical Vein Endothelial Cells</topic><topic>Humans</topic><topic>HUVEC</topic><topic>KLF2</topic><topic>Kruppel-Like Transcription Factors - genetics</topic><topic>Kruppel-Like Transcription Factors - metabolism</topic><topic>Micro-RNA 200b</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>Neovascularization, Physiologic - genetics</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bartoszewski, Rafal</creatorcontrib><creatorcontrib>Serocki, Marcin</creatorcontrib><creatorcontrib>Janaszak-Jasiecka, Anna</creatorcontrib><creatorcontrib>Bartoszewska, Sylwia</creatorcontrib><creatorcontrib>Kochan-Jamrozy, Kinga</creatorcontrib><creatorcontrib>Piotrowski, Arkadiusz</creatorcontrib><creatorcontrib>Króliczewski, Jarosław</creatorcontrib><creatorcontrib>Collawn, James F.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of cell biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bartoszewski, Rafal</au><au>Serocki, Marcin</au><au>Janaszak-Jasiecka, Anna</au><au>Bartoszewska, Sylwia</au><au>Kochan-Jamrozy, Kinga</au><au>Piotrowski, Arkadiusz</au><au>Króliczewski, Jarosław</au><au>Collawn, James F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>miR-200b downregulates Kruppel Like Factor 2 (KLF2) during acute hypoxia in human endothelial cells</atitle><jtitle>European journal of cell biology</jtitle><addtitle>Eur J Cell Biol</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>96</volume><issue>8</issue><spage>758</spage><epage>766</epage><pages>758-766</pages><issn>0171-9335</issn><eissn>1618-1298</eissn><abstract>The role of microRNAs in controlling angiogenesis is recognized as a promising therapeutic target in both cancer and cardiovascular disorders. However, understanding a miRNA’s pleiotropic effects on angiogenesis is a limiting factor for these types of therapeutic approaches. Using genome-wide next-generation sequencing, we examined the role of an antiangiogenic miRNA, miR-200b, in primary human endothelial cells. The results indicate that miR-200b has complex effects on hypoxia-induced angiogenesis in human endothelia and importantly, that many of the reported miR-200b effects using miRNA overexpression may not be representative of the physiological role of this miRNA. We also identified the antiangiogenic KLF2 gene as a novel target of miR-200b. Our studies indicate that the physiological changes in miR-200b levels during acute hypoxia may actually have a proangiogenic effect through Klf2 downregulation and subsequent stabilization of HIF-1 signaling. Moreover, we provide a viable approach for differentiating direct from indirect miRNA effects in order to untangle the complexity of individual miRNA networks.</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>29042072</pmid><doi>10.1016/j.ejcb.2017.10.001</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0171-9335
ispartof European journal of cell biology, 2017-12, Vol.96 (8), p.758-766
issn 0171-9335
1618-1298
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5677561
source ScienceDirect Journals
subjects Cell Hypoxia - genetics
Down-Regulation
HIF-1
HIF-2
hsa-miR-200b-3p
Human Umbilical Vein Endothelial Cells
Humans
HUVEC
KLF2
Kruppel-Like Transcription Factors - genetics
Kruppel-Like Transcription Factors - metabolism
Micro-RNA 200b
MicroRNAs - genetics
MicroRNAs - metabolism
Neovascularization, Physiologic - genetics
RNA, Messenger - genetics
RNA, Messenger - metabolism
Transfection
title miR-200b downregulates Kruppel Like Factor 2 (KLF2) during acute hypoxia in human endothelial cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T13%3A27%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=miR-200b%20downregulates%20Kruppel%20Like%20Factor%202%20(KLF2)%20during%20acute%20hypoxia%20in%20human%20endothelial%20cells&rft.jtitle=European%20journal%20of%20cell%20biology&rft.au=Bartoszewski,%20Rafal&rft.date=2017-12-01&rft.volume=96&rft.issue=8&rft.spage=758&rft.epage=766&rft.pages=758-766&rft.issn=0171-9335&rft.eissn=1618-1298&rft_id=info:doi/10.1016/j.ejcb.2017.10.001&rft_dat=%3Cproquest_pubme%3E1952525383%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-32ff75fb3eb0c45433285090230a18434b8532d9c18be045fe1229d12eb58d3b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1952525383&rft_id=info:pmid/29042072&rfr_iscdi=true